Table 3.
Ocular surface squamous neoplasia with intraocular tumour extension: treatment, outcome and histopathology features
| Feature | n (%) n = 23 |
|---|---|
| Primary treatment | |
| Extended enucleation | 8 (35) |
| Orbital exenteration | 15 (65) |
| Adjuvant treatment post-excisional biopsy | |
| Mitomycin-C | 2 (9) |
| Plaque radiotherapy | 2 (9) |
| Secondary treatment for tumour recurrence post-extended enucleation | |
| Orbital exenteration | 2 (9) |
| Outcome | |
| Locoregional lymph node metastasis | 2 (9) |
| Systemic metastasis | 0 (0) |
| Death | 0 (0) |
| Tumour type | |
| Invasive squamous cell carcinoma | 22 (96) |
| Mucoepidermoid variant | 1 (4) |
| Tumour differentiation | |
| Well-differentiated | 17 (74) |
| Moderately differentiated | 5 (22) |
| Poorly differentiated | 1 (4) |
| Intraocular structure invaded by the tumour | |
| Iris | 0 (0) |
| Iris + ciliary body | 5 (22) |
| Iris + ciliary body + choroid | 6 (26) |
| Ciliary body | 7 (30) |
| Ciliary body + choroid | 5 (22) |
| Associated intraocular inflammation | 11 (48) |